October 25, 2023
RegMed Investors (RMi) Closing Bell: yet another sector share pricing reverse
October 24, 2023
RegMed Investors (RMi) Closing Bell: elevating the oversold with help from “uncle algo”
October 23, 2023
RegMed Investors (RMi) Closing Bell: continued sentiment difficulties with an extreme risk adverse investor psychology
October 20, 2023
RegMed Investors (RMi) Closing Bell: cauterizing a wound after a portfolio whack, almost
October 19, 2023
RegMed Investors (RMi) Closing Bell: buyers, wherefore art thou?
October 18, 2023
RegMed Investors (RMi) Closing Bell: staring into the abyss after scrambling into safety
October 17, 2023
RegMed Investors (RMi) Closing Bell: a lot of background noise
October 16, 2023
RegMed Investors (RMi) Closing Bell: When you’re on a roller coaster, you can be sure you’ll end up back where you started
October 13, 2023
RegMed Investors (RMi) Closing Bell: winning the tug-of-war
October 12, 2023
RegMed Investors (RMi) Closing Bell: The Scorpion and the Frog
October 11, 2023
RegMed Investors (RMi) Closing Bell: who gives a damn?
October 10, 2023
RegMed Investors (RMi) Closing Bell: Falling bond yields lifted cell and gene therapy sector equities
October 9, 2023
RegMed Investors (RMi) Closing Bell: sector interruptus
October 6, 2023
RegMed Investors (RMi) Closing Bell: a “good news is bad news” conundrum
October 5, 2023
RegMed Investors (RMi) Closing Bell: I won’t apologize for providing need-to-know “facts in evidence”
October 4, 2023
RegMed Investors (RMi) Closing Bell: not in the cards for cell and gene therapy sector
October 3, 2023
RegMed Investors (RMi) Closing Bell: When you’re on a roller coaster
October 2, 2023
RegMed Investors (RMi) Closing Bell: bottoms up
September 29, 2023
RegMed Investors (RMi) Closing Bell: the end
September 28, 2023
RegMed Investors (RMi) Closing Bell: as I had asked on Tuesday, how long will the upside last?
September 27, 2023
RegMed Investors (RMi) Closing Bell: as I asked this a.m., how long will Tuesday’s upside last?
September 26, 2023
RegMed Investors (RMi) Closing Bell: sector was at its worst just before share pricing got better
September 25, 2023
RegMed Investors (RMi) Closing Bell: Humpty Dumpty had a great fall
September 22, 2023
RegMed Investors (RMi) Closing Bell: no joy
September 21, 2023
RegMed Investors (RMi) Closing Bell: sector got scalped
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2023 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.